Advertisement
A sampling of outcomes and volumes from the top U.S. heart program
Perspectives from leading Cleveland Clinic co-investigators
How Cleveland Clinic helped a Missouri center launch its program
Insights emerge on influence of severity, access route
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
FDA approvals for valve-in-valve TAVR follow clearance of 3rd-generation valve
Broader preprocedure MRI and neurocognitive testing indicated
Percutaneous aortic and mitral approaches proliferate
Final outcomes report changes treatment paradigm
TAVR an acceptable alternative to surgery in patients at high surgical risk
Here’s where this state-of-the-art treatment stands
Advertisement
Advertisement